文献速递生殖医学

进口玻璃化捐赠卵子周期临床策略:每对夫妇至少8枚卵子与单囊胚移植

Definition of a clinical strategy to enhance the efficacy, efficiency and safety of egg donation cycles with imported vitrified oocytes.
PubMed 文献 · Hum Reprod · 2020-01-01

该纵向队列研究纳入273对夫妇,使用从三家西班牙卵子库进口的玻璃化捐赠卵子进行IVF。结果显示,每周期 warming 至少8枚卵子与较高的累积活产率相关,且单囊胚移植策略可最大限度降低多胎妊娠风险。

要点

  • 每对夫妇进口至少8枚玻璃化卵子可获较高累积活产率。
  • 单囊胚移植策略可显著降低多胎妊娠及相关产科并发症。
  • warming 8-9枚卵子相比6-7枚,累积活产率OR为2.5。

核心结论

  • 每周期 warming 至少8枚进口玻璃化卵子与高累积活产率相关,并支持自信地采用单囊胚移植以最小化多胎妊娠风险。

研究设计与样本

  • 纵向队列研究,2015年10月至2018年12月在两家私立IVF中心进行,共273对夫妇(平均母亲年龄42.5±3.5岁,范围31-50岁;平均捐赠者年龄25.7±4.2岁,范围20-35岁),使用从三家西班牙卵子库购买的卵子。

主要发现

  • warming后存活率为86±16%。
  • warming 6、7、8和9枚卵子时,周期完成率分别为94%、100%、72%和70%,每完成周期的累积活产率分别为35%、44%、69%和59%。
  • 存活≤4、5、6、7、8和9枚卵子时,周期完成率分别为98%、94%、85%、84%、66%和68%,每完成周期的累积活产率分别为16%、46%、50%、61%、76%和60%。
  • 多因素logistic回归校正捐赠者年龄和卵子库后,warming 8-9枚卵子相比6-7枚,每完成周期累积活产率的OR为2.5(95%CI:1.07-6.03,P=0.03);存活7-9枚相比≤6枚,OR为2.7(95%CI:1.28-5.71,P<0.01)。
  • 卵裂期胚胎移植时,17%(28/162)采用单胚胎移植,每移植活产率26%(43/162),足月妊娠中28%(12/43)为双胎;囊胚移植时,96%(224/234)采用单胚胎移植,每移植活产率30%(70/234),足月妊娠均为单胎(70/70)。

关键数值与推荐

  • 当warming 8-9枚卵子相比6-7枚,累积活产率OR=2.5(95%CI:1.07-6.03,P=0.03)。
  • 当存活7-9枚卵子相比≤6枚,累积活产率OR=2.7(95%CI:1.28-5.71,P<0.01)。
  • 卵裂期与囊胚期移植策略比较,唯一显著差异是低出生体重发生率:34% vs 5%(P<0.01)。
  • 单胎与双胎妊娠比较:出生体重3048±566g vs 2271±247g(P<0.01),孕周38±2 vs 36±2周(P<0.01),剖宫产72% vs 100%(P=0.02),低出生体重8% vs 86%(P<0.01),小于胎龄儿24% vs 57%(P=0.02),早产25% vs 86%(P<0.01)。

临床怎么用

  • 在进口玻璃化捐赠卵子周期中,建议每对夫妇分配至少8枚卵子以提高累积活产率。
  • 优先采用单囊胚移植策略,以维持较高成功率并减少双胎妊娠相关产科并发症。

局限性

  • 回顾性研究,需在多中心及更大样本量中验证以提高亚组分析准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Which is the most suitable clinical strategy in egg donation IVF cycles conducted with imported donated vitrified oocytes? SUMMARY ANSWER: The importation, and allocation, of at least eight vitrified eggs per couple during an egg donation cycle is associated with a high cumulative live birth delivery rate per cycle, as well as the confident adoption of a single blastocyst transfer strategy to minimize the risk of multiple pregnancies. WHAT IS KNOWN ALREADY: IVF using donor eggs is commonly used worldwide to treat women who are unable to conceive with their own oocytes. In 2014, the Constitutional Court (n.162/2014) gave permission for gamete donation to be allowed for ART in Italy. Initially recommended as a therapeutic approach for premature ovarian insufficiency, the use of donated oocytes has become more and more common. In countries such as Italy, fresh oocyte donation is theoretically possible, but practically impossible due to the lack of donors. In fact, the Italian law does not allow reimbursement to the young women, who can only voluntarily donate their eggs. Therefore, Italian IVF centers have established several collaborations with international oocyte cryo-banks. The most popular workflow involves the importation of donated oocytes that have been vitrified. However, recent evidence has questioned the overall efficacy of such an approach. This is because detrimental effects arising from oocyte vitrification and warming might reduce the number of eggs available for insemination, with a consequential reduction in the achievable live birth rate per cycle. STUDY DESIGN, SIZE, DURATION: This was a longitudinal cohort study, conducted between October 2015 and December 2018 at two private IVF centers. Overall, 273 couples were treated (mean maternal age: 42.5 ± 3.5 years, range: 31-50 years; mean donor age: 25.7 ± 4.2, 20-35 years) with oocytes purchased from three different Spanish egg banks. PARTICIPANTS/MATERIALS, SETTING, METHODS: We performed an overall analysis, as well as several sub-analyses clustering the data according to the year of treatment (2015-2016, 2017 or 2018), the number of warmed (6, 7, 8 or 9) and surviving oocytes (≤4, 5, 6, 7, 8 or 9) and the cycle strategy adopted (cleavage stage embryo transfer and vitrification, cleavage stage embryo transfer and blastocyst vitrification, blastocyst stage embryo transfer and vitrification). This study aimed to create a workflow to maximize IVF efficacy, efficiency, and safety, during egg donation cycles with imported vitrified oocytes. The primary outcome was the cumulative live birth delivery rate among completed cycles (i.e. cycles where at least a delivery of a live birth was achieved, or no embryo was produced/left to transfer). All cycles, along with their embryological, obstetric and neonatal outcomes, were registered and inspected. MAIN RESULTS AND THE ROLE OF CHANCE: The survival rate after warming was 86 ± 16%. When 6, 7, 8 and 9 oocytes were warmed, 94, 100, 72 and 70% of cycles were completed, resulting in 35, 44, 69 and 59% cumulative live birth delivery rates per completed cycle, respectively. When ≤4, 5, 6, 7, 8 and 9 oocytes survived, 98, 94, 85, 84, 66 and 68% of cycles were completed, resulting in 16, 46, 50, 61, 76 and 60% cumulative live birth delivery rates per completed cycle, respectively. When correcting for donor age, and oocyte bank, in a multivariate logistic regression analysis, warming eight to nine oocytes resulted in an odds ratio (OR) of 2.5 (95% CI: 1.07-6.03, P = 0.03) for the cumulative live birth delivery rate per completed cycle with respect to six to seven oocytes. Similarly, when seven to nine oocytes survived warming, the OR was 2.7 (95% CI: 1.28-5.71, P < 0.01) with respect to ≤6 oocytes. When cleavage stage embryos were transferred, a single embryo transfer strategy was adopted in 17% of cases (N = 28/162); the live birth delivery rate per transfer was 26% (n = 43/162), but among the pregnancies to term, 28% involved twins (n = 12/43). Conversely, when blastocysts were transferred, a single embryo transfer strategy was adopted in 96% of cases (n = 224/234) with a 30% live birth delivery rate per transfer (N = 70/234), and the pregnancies to term were all singleton (n = 70/70). During the study period, 125 babies were born from 113 patients. When comparing the obstetric outcomes for the cleavage and blastocyst stage transfer strategies, the only significant difference was the prevalence of low birthweight: 34 versus 5%, respectively (P < 0.01). However, several significant differences were identified when comparing singleton with twin pregnancies; in fact, the latter resulted in a generally lower birthweight (mean ± SD: 3048 ± 566 g versus 2271 ± 247 g, P < 0.01), a significantly shorter gestation (38 ± 2 versus 36 ± 2 weeks, P < 0.01), solely Caesarean sections (72 versus 100%, P = 0.02), a higher prevalence of low birthweight (8 versus 86%, P < 0.01), small newborns for gestational age (24 versus 57%, P = 0.02) and preterm births (25 versus 86%, P < 0.01). LIMITATIONS, REASONS FOR CAUTION: This retrospective study should now be confirmed across several IVF centers and with a greater sample size in order to improve the accuracy of the sub-analyses. WIDER IMPLICATIONS OF THE FINDINGS: Single blastocyst transfer is the most suitable approach to achieve high success rates per procedure, thereby also limiting the obstetric complications that arise from twin pregnancies in oocyte donation programs. In this regard, the larger the cohort of imported donated vitrified oocytes, the more efficient the management of each cycle. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: None.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Rienzi L, Cimadomo D, Maggiulli R, et al. Definition of a clinical strategy to enhance the efficacy, efficiency and safety of egg donation cycles with imported vitrified oocytes. Hum Reprod. 2020. PMID: 32240287. doi:10.1093/humrep/deaa009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。